INNOVIVA, INC. Increase (Decrease) in Other Noncurrent Liabilities
INNOVIVA, INC. (INVA) reported Increase (Decrease) in Other Noncurrent Liabilities of $0 for the 12-month period ending 2021-12-31, per its 10-K/A filed 2022-03-17.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentLiabilities · last filed 2022-03-17
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2020-12-31 was $0.00.
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2019-12-31 was $0.00.
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2019-09-30 was -$126.00K.
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for the quarter ending 2019-06-30 was $0.00, a 100.00% decline year-over-year.
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for fiscal 2021 was $0.00.
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for fiscal 2020 was $0.00.
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for fiscal 2019 was -$126.00K, a 3250.00% decline from fiscal 2018.
- INNOVIVA, INC. increase (decrease) in other noncurrent liabilities for fiscal 2018 was $4.00K, a 75.00% decline from fiscal 2017.
| Period end | Increase (Decrease) in Other Noncurrent Liabilities 3 month | Increase (Decrease) in Other Noncurrent Liabilities 6 month | Increase (Decrease) in Other Noncurrent Liabilities 9 month | Increase (Decrease) in Other Noncurrent Liabilities 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 10-K/A · filed 2022-03-17 | |||
| 2020-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | $0.00 10-K/A · filed 2022-03-17 | ||
| 2020-09-30 | $0.00 10-Q · filed 2020-10-28 | |||
| 2019-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2022-03-17 | -$126.00K derived: sum of 2 quarters · filed 2022-03-17 | -$126.00K derived: sum of 3 quarters · filed 2022-03-17 | -$126.00K 10-K/A · filed 2022-03-17 |
| 2019-09-30 | -$126.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-28 | -$126.00K derived: sum of 2 quarters · filed 2020-10-28 | -$126.00K 10-Q · filed 2020-10-28 | -$126.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $0.00 10-Q · filed 2019-07-24 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $0.00 derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $0.00 10-Q · filed 2019-05-01 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $0.00 derived: sum of 3 quarters · filed 2021-02-25 | $2.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $0.00 derived: sum of 2 quarters · filed 2021-02-25 | $2.00K derived: sum of 3 quarters · filed 2021-02-25 | $4.00K 10-K · filed 2021-02-25 |
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $2.00K derived: sum of 2 quarters · filed 2019-10-30 | $4.00K 10-Q · filed 2019-10-30 | $7.00K derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-24 | $4.00K 10-Q · filed 2019-07-24 | $7.00K derived: sum of 3 quarters · filed 2020-02-19 | $10.00K derived: sum of 4 quarters · filed 2020-02-19 |
| 2018-03-31 | $2.00K 10-Q · filed 2019-05-01 | $5.00K derived: sum of 2 quarters · filed 2020-02-19 | $8.00K derived: sum of 3 quarters · filed 2020-02-19 | $13.00K derived: sum of 4 quarters · filed 2020-02-19 |
| 2017-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $6.00K derived: sum of 2 quarters · filed 2020-02-19 | $11.00K derived: sum of 3 quarters · filed 2020-02-19 | $16.00K 10-K · filed 2020-02-19 |
| 2017-09-30 | $3.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-31 | $8.00K derived: sum of 2 quarters · filed 2018-10-31 | $13.00K 10-Q · filed 2018-10-31 | $19.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-06-30 | $5.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-07-26 | $10.00K 10-Q · filed 2018-07-26 | $16.00K derived: sum of 3 quarters · filed 2019-02-19 | $96.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2017-03-31 | $5.00K 10-Q · filed 2018-05-04 | $11.00K derived: sum of 2 quarters · filed 2019-02-19 | $91.00K derived: sum of 3 quarters · filed 2019-02-19 | $15.00K derived: sum of 4 quarters · filed 2019-02-19 |
| 2016-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-19 | $86.00K derived: sum of 2 quarters · filed 2019-02-19 | $10.00K derived: sum of 3 quarters · filed 2019-02-19 | $8.00K 10-K · filed 2019-02-19 |
| 2016-09-30 | $80.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-03 | $4.00K derived: sum of 2 quarters · filed 2017-11-03 | $2.00K 10-Q · filed 2017-11-03 | $0.00 derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-06-30 | -$76.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | -$78.00K 10-Q · filed 2017-08-08 | -$80.00K derived: sum of 3 quarters · filed 2018-02-23 | -$82.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-03-31 | -$2.00K 10-Q · filed 2017-05-05 | -$4.00K derived: sum of 2 quarters · filed 2018-02-23 | -$6.00K derived: sum of 3 quarters · filed 2018-02-23 | $7.00K derived: sum of 4 quarters · filed 2018-02-23 |
| 2015-12-31 | -$2.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | -$4.00K derived: sum of 2 quarters · filed 2018-02-23 | $9.00K derived: sum of 3 quarters · filed 2018-02-23 | -$7.00K 10-K · filed 2018-02-23 |
| 2015-09-30 | -$2.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $11.00K derived: sum of 2 quarters · filed 2016-11-03 | -$5.00K 10-Q · filed 2016-11-03 | |
| 2015-06-30 | $13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-04 | -$3.00K 10-Q · filed 2016-08-04 | ||
| 2015-03-31 | -$16.00K 10-Q · filed 2016-05-05 | |||
| 2014-12-31 | $275.00K 10-K · filed 2017-02-28 | |||
| 2013-12-31 | -$299.00K 10-K · filed 2016-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ArriVent BioPharma, Inc. (AVBP) | United States | $1.485B | -10.25 |
| Ultragenyx Pharmaceutical Inc. (RARE) | United States | $1.456B | -5.62 |
| OMEROS CORP (OMER) | United States | $1.456B | 5.50 |
| ANAPTYSBIO, INC (ANAB) | United States | $1.546B | -60.20 |
| Kailera Therapeutics, Inc. (KLRA) | United States | $1.552B | |
| Syndax Pharmaceuticals Inc (SNDX) | United States | $1.606B | -8.82 |
| Oric Pharmaceuticals, Inc. (ORIC) | United States | $1.367B | -8.00 |
| Rapport Therapeutics, Inc. (RAPP) | United States | $1.623B | -14.56 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |